sglt2 inhibitors vs glp-1 agonists Combining Receptor and in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique Metabolic Powerhouses: GLP-1 RAs and

Myth: More ingredients = better results. Fact: More ingredients can also mean more variables (tolerability, interactions, unclear dosing)

GLP-1 medications have taken the weight loss conversation by storm

& Papazova, M

When recovery improves, people may be able to: Exercise more frequently Return to workouts sooner Increase overall activity levels Stay consistent with training Over time, these factors can contribute to weight loss and improvements in body composition

Similarly, for dual/triple agonists, regulatory agencies will demand evidence of incremental benefit vs risk over existing agents

Debjit BhowmikCKumarKSChandiraMJayakarB